Skip to main content
. Author manuscript; available in PMC: 2017 Dec 15.
Published in final edited form as: Mucosal Immunol. 2017 Jun 14;11(2):345–356. doi: 10.1038/mi.2017.52

Fig. 6. Effects of IL13Rα2 knockdown.

Fig. 6

A. Representative western blots of different clones of HT-29/B6 cells stably transfected with shRNA against IL13Rα2 (shRα2) in comparison with vector-transfected controls. B. Densitometric analysis of tricellulin and IL13Rα2 expression in shRα2 knockdown clones (n=4; **p<0.01). C. Representative western blots of vector controls and shRα2 clones treated with IL-13. D. Densitometric analysis of tricellulin expression in shRα2 and vector control clones in response to IL-13-treatment (n=6; ***p<0.001). E. Permeability for 4 kDa-FITC dextran. Permeability for FD4 is increased in vector controls treated with IL-13, while in IL13Rα2 knockdown, no effect is observed after IL-13 treatment (n=8–13; *p<0.05).